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Abstract
Point mutations resulting in the substitution of a single amino acid can cause severe functional consequences, but can also be
completely harmless. Understanding what determines the phenotypical impact is important both for planning targeted
mutation experiments in the laboratory and for analyzing naturally occurring mutations found in patients. Common wisdom
suggests using the extent of evolutionary conservation of a residue or a sequence motif as an indicator of its functional
importance and thus vulnerability in case of mutation. In this work, we put forward the hypothesis that in addition to
conservation, co-evolution of residues in a protein influences the likelihood of a residue to be functionally important and thus
associated with disease. While the basic idea of a relation between co-evolution and functional sites hasbeenexplored before,
we have conducted the first systematic and comprehensive analysis of point mutations causing disease in humans with
respect to correlated mutations. We included 14,211 distinct positions with known disease-causing point mutations in 1,153
human proteins in our analysis. Our data show that (1) correlated positions are significantly more likely to be disease-
associated than expected by chance, and that (2) this signal cannot be explained by conservation patterns of individual
sequence positions. Although correlated residues have primarily been used to predict contact sites, our data are in agreement
with previous observations that (3) many such correlations do not relate to physical contacts between amino acid residues.
Access to our analysis results are provided at http://webclu.bio.wzw.tum.de/,pagel/supplements/correlated-positions/.
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Introduction
Most of the missense mutations do not lead to an appreciable
phenotype when they occur in nature or are introduced
experimentally. There are, however, numerous counterexamples
where even a subtle change of the primary protein sequence results
in severe phenotypical effects – i.e. genetic disease. Understanding
the underlying mechanisms which determine the link between
genotype and phenotype is the key issue in developing strategies
for diagnosis and treatment of hereditary diseases.
Databases such as OMIM (Online Mendelian Inheritance in
Man) or HGMD (Human Gene Mutation Database) provide a
wealth of information [1,2] about phenotypes associated with
thousands of known human mutations. These databases assist
researchers in analyzing the molecular basis of human disease. With
the current quest for the ‘‘1000 Dollar Genome’’, there is no doubt
that entire patient genomes will be available in the near future
which will substantially accelerate the discovery of new mutations of
unknown significance. In such a situation the question ‘‘What does
this mutation mean for a patient’s health?’’ will become more and
more practical for the affected individuals and physicians.
Properties of ‘‘disease proteins’’
What rules determine the spectrum of allowed mutations, and
why do mutations cause disease in some genes while other genes
appear to be more tolerant to substitutions? Much effort has been
invested in answering such questions and promoting our
understanding of the underlying mechanisms which rule the
complex network of factors contributing to human disease. In
particular, we would like to understand what properties or features
are shared by disease-associated genes.
In addition to numerous careful experiments on individual
genes and proteins, with the advent of high-throughput technol-
ogies such as genomics, proteomics and, more recently, metabo-
lomics large bodies of experimental data have been analyzed
towards this end. It has been shown that genes and proteins, which
are known to be involved in a large variety of diseases and
syndromes, differ from genes without such association in many
aspects. Disease genes have a broader phylogenetic distribution,
tend to be longer on average, and more of them have homologs in
other mammals compared to the average human gene [3].
Disease-related proteins have been found to be better conserved
and their synonymous substitution rates are significantly higher
than expected [4,5]. Further contributions demonstrated that
disease proteins have less designable folds, tend to have isoelectric
points closer to neutrality, contain more alternating hydrophilic/
hydrophobic stretches compared to the average human protein
and have a higher tendency to aggregate [6]. ‘‘Disease genes’’ are
highly expressed in a small number of tissues, and their encoded
proteins are more likely to be secreted and mutated in genetic
PLoS Computational Biology | www.ploscompbiol.org 1 September 2010 | Volume 6 | Issue 9 | e1000923diseases with Mendelian inheritance [7]. Finally, genes associated
with inherited disease mutations are less likely to be essential and
display an intermediate level of connectivity on protein interaction
networks [8].
Identification of critical residues
Knowing what genes and proteins are involved in disease is only
one part of the challenge. Clearly, not every site of a protein is
equally vulnerable when hit by mutations. While some parts of the
molecule will remain functional even after substantial changes of
the primary sequence, other positions cannot be changed at all
without serious consequences. Evolutionary conserved and
functionally important residues, such as those in active centers of
enzymes, as well as residues important for preservation of the
protein’s overall stability, in particular those located in buried
positions, have been shown to be frequent targets of disease-
associated mutations [9,10], and multiple prediction techniques
based on both structural and sequence features of proteins have
been suggested to distinguish benign mutations from those
implicated in inherited disease. Notable tools to combine multiple
lines of evidence to produce more reliable prediction include SIFT
and PolyPhen [11,12] (see [13] for an excellent review).
Correlated mutations
The phenomenon of correlated mutational behavior between
columns of a multiple sequence alignment has been described for
many years for both DNA/RNA and protein sequences [14–16].
For proteins, the initially hypothesized notion of the underlying
biological event was, that an unfavorable amino acid change in a
structural contact site may go without negative consequences if its
direct binding partner is simultaneously mutated in such a way
that the original interaction is salvaged (compensatory mutation).
Accordingly, the analysis of such correlated mutations has been
traditionally employed for the identification of residue contact
pairs within or between different protein chains. The first
approach to detect co-evolving residues in a multiple sequence
alignment was proposed in 1994 [17]. Many other methods have
been reported since then and evaluated with respect to their
potential of predicting residue-residue contacts [18–24]. However,
despite significant progress in method development, comparative
studies have shown that prediction accuracies for structural
contacts hardly exceed 20% with any of these methods [25],
strongly limiting the application of the predicted contacts as
structural constraints in ab initio structure prediction.
While some authors have explained the low contact prediction
accuracies with the difficulty of differentiating correlation signal
from random noise [26,27], recent studies indicate that co-
evolution of amino acids in fact may originate not only from
structural contacts but from a much broader range of biological
reasons. Using Statistical Coupling Analysis Ranganathan et al.
(2005) detected correlation rules in the WW domain which
describe aspects of the fold architecture going beyond simple
protein contacts. They introduced the concept of a correlation
backbone in the fold which they claimed was nearly sufficient to
describe the architecture without additional information [28].
They impressively demonstrated the power of this idea by
synthesizing artificial WW domains solely based on the previously
derived correlation model and showing that a substantial
percentage of these designed polypeptides were able to fold into
functional WW domains in vitro [29].
In addition, further contributions have demonstrated that
correlated mutations may also occur due to reasons related to
protein function. Gloor et al. analyzed 12 mutations of the ATP
synthase e subunit and 7 mis-sense mutations of the homeodomain
and came to the conclusion that certain co-evolving residues are
more likely to be functional sites and thus possibly more likely to
be related to disease [18]. Within a study on the Hsp70-Hop-
Hsp90 system, regions previously known to be functionally
important could be identified based on residue co-evolution
[30]. Additionally, the authors pointed out that co-evolving amino
acids were often found to be in close proximity to functionally
important sites. Similar results were obtained in an analysis of
correlated mutations within the cytochrome c oxidase subunit I
where many co-evolving residues were found adjacent to
hypothesized proton pumping channels [31]. In a recent
publication Lee et al. provided further evidence for the hypothesis
that correlated mutation may be related to functional importance
in an analysis of 44 selected protein families [32].
All together, these results indicate that co-evolving residues may
be both structurally or functionally important positions within
protein folds and therefore could be likely targets for disease-
associated point mutations. Here, we present the first comprehen-
sive analysis of human disease mutations with respect to co-
evolving residues using all known point mutations and proteins
currently available in the Human Gene Mutation Database
(HGMD). Our data confirm that correlated mutations go well
beyond contact prediction and are a hallmark of amino acid
positions leading to disease when affected by mutation.
Results
Forour analysis,weused all humanproteinsknownto beaffected
by at least one disease causing point mutation according to HGMD
annotation and for which at least 30 orthologous proteins of
sufficient sequence diversity were available for building a multiple
sequence alignment. 1153 proteins fulfilled all requirements and
were analyzed for correlated mutations using the OMES algorithm.
In addition, we repeated all analyses on a more rigorous dataset
using a cutoff of § 125 proteins per ortholog cluster which left us
with 855 human disease proteins. Using these two data sets, we
identified 62 365 and 46 022 residues as correlated with other
positions, respectively. A total of 14211 and 10508 positions were
found to be disease-related in these two sets.
Author Summary
Point mutations (i.e., changes of a single sequence element)
can have a severe impact on protein function. Many
diseases are caused by such minute defects. On the other
hand, the majority of such mutations does not lead to
noticeable effects. Although previous research has revealed
important aspects that influence or predict the chance of a
mutation to cause disease, much remains to be learned
before we fully understand this complex problem. In our
work, we use the observation that sometimes certain
positions in a protein mutate in an apparently correlated
fashion and analyze this correlation with respect to
mutation vulnerability. Our results show that positions
exhibiting evolutionary correlation are significantly more
likely to be vulnerable to mutation than average positions.
On one hand, our data further support the concept of
correlated positions to not only be associated with protein
contacts but also functional sites and/or disease positions
(as introduced by others). On the other hand, this could be
useful to further improve the understanding and prediction
of the consequences of mutations. Our work is the first to
attempt a large-scale quantitation of this relationship.
Correlated Disease Mutations
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As stated above, our work is motivated by the observation that
co-mutation of residues over the course of evolution may not to be
restricted to protein contacts but rather be the result of other types
of functional association among residues. Accordingly, our first
goal was to test the hypothesis that point mutations affecting
correlated residues are more likely to result in disease than
expected by chance (i.e. compared to random positions).
Using all residues represented in the datasets described above,
we produced contingency tables of correlatedness vs. known
disease-mutations. Based on these tables, we computed the
background rates of disease mutations to be 0.019% for random
positions and 0.032% for correlated positions (0.0195 and 0.0325
for the clusters § 125). In other words, correlated residues were
found to be &1:66 times more likely to be known disease positions
than expected by chance translating to a log odds value (LOD,
log2
P(DiseaseDCorrelated)
P(Disease)
) of 0.73.
For the clusters §125, the relative increase was found to be
1.66 (LOD~0:74). Fisher’s exact test for count data confirmed
that the observed difference is highly significant in both cases
(pv2:2:10{16; see Table 1 for summary). As the stringent data did
not yield a substantial gain over the less strict set, we are reporting
the results of the latter (§ 30) data in the subsequent text. All
results for the stringent set are reported in the Text S1.
Figure 1 shows the empirical background distribution of LOD
values generated by 1000-fold permutation of correlation scores in
comparison to the observed LOD. In addition, we show the
bootstrap distribution of the observed LOD generated by 1000fold
resampling of individual positions from all multiple sequence
alignments (same as 8.1 in Text S1). Clearly, the observed value is
far outside the background distribution.
In order to cross-check our findings, we also computed the LOD
for a set of positions that are highly unlikely to be associated with
disease because of evolutionary accepted mutations (see Materials
and Methods). In this data we find an LOD of 21.26 indicating
that these positions are clearly underrepresented in the set of
correlated positions.
Impact on individual proteins
After having shown that correlated positions are in general
significantly more likely to be hit by disease-causing point
mutations we sought to investigate the implications of this finding
for individual proteins. We repeated the above analysis for all 1153
proteins separately. As both the number of known disease-
mutations and the degree of correlation varies among proteins,
one would expect that for some proteins, correlation is strongly
associated with disease-susceptibility while in others no such signal
can be detected. In fact, analysis of individual proteins also yields
an arithmetic annoyance: proteins with a very low number of
known disease mutations have a very large chance that none of
them is located in a correlated position simply because of the small
sample size, resulting in an LOD~{?. These cases were
excluded from the following analysis as no valid statistical analyses
could be carried out. In total, an LOD score could be calculated
for 524 proteins of the data set and 629 proteins obtained no score.
The analysis of the proteins for which our approach failed shows
that 50% (315) of these proteins have only one known disease
mutation in HGMD and for only 3.8% (24) more than 9 disease-
related substitutions were available.
The LOD distribution for individual proteins is depicted in
Figure 2 (Alignment threshold §30; see Text S1 for threshold
§125). Only a small fraction of proteins (10% in Figure 2a) in our
data set had LOD values ƒ0 and a clear majority of proteins had
at least slightly positive LODs. In some cases, we observed LOD
scores w4:0 which represents an increase of 1500% over
expectation. Taken together, these numbers indicate that, except
for cases with very few known disease mutations, the global result
applies to the majority of individual proteins.
What about conservation?
Detection of correlated residue pairs is not entirely independent
of the degree of conservation of the respective positions.
Depending on the algorithm used, substantial crosstalk between
conservation and correlation can be observed [25]. Although the
Table 1. Influence of the alignment threshold on disease enrichment in correlated positions.
Alignment cutoff TD C D ^ C LOD p-value
§30 741436 14211 62365 1988 0.73 v2:2:10{16
§125 538283 10508 46022 1498 0.735 v2:2:10{16
P-values were computed using Fisher’s exact test. As both selection methods achieve positive LOD score and highly significant p-values this result indicates that
disease-causing mutations are overrepresented in correlated positions. T: number of all residues; D: number of disease mutations; C: number of correlated positions;
D ^ C: number of correlated residues affected by disease-associated mutations.
doi:10.1371/journal.pcbi.1000923.t001
Figure 1. Disease mutations occur significantly more often in
correlated positions than expected. Black: Empirical background
distribution obtained by 1000 permutations (random expectation).
Grey: Bootstrap distribution of observed LOD. Dotted vertical line
indicates the observed LOD obtained by an alignment cutoff of §30.
doi:10.1371/journal.pcbi.1000923.g001
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approaches with respect to interactions with conservation, we
investigated the degree to which sequence conservation affects our
results. This is especially important as evolutionary conservation of
a sequence region is generally taken as an indication of functional
importance and thus would represent a bias in favor of the
hypothesis under test.
We calculated two different measures of conservation for each
position in the multiple sequence alignments. The first method
(cident) computes fractional identity to the human (reference)
residues in each column of the MSA. The second procedure
(cblosum) computes a conservation score based on the BLOSUM62
amino acid substitution-matrix [33] for each column.
To evaluate the interaction between correlation and conservation
we applied stepwise filtering on conservation. Starting from the full
dataset, we decremented the conservation threshold ^ c c in small steps
thus removing more and more of the top conserved columns from
the MSA. The background frequency P(Disease) as well as the
observed frequency P(DiseaseDCorrelated) of all positions was re-
computed for all of these filtered datasets and the corresponding
LOD values were computed. Figure 3(A,B) shows LOD values
plotted againstthe respective conservation cutoff^ c c.E . g .^ c cblosum~0:4
indicates that for the calculation of the global LOD score only
residues with cblosumƒ0:4 were taken into account.
For comparison, we also computed the LOD score of conservation
with respect to disease mutations. Our initial intuition was that
conservation would probably be a much more potent indicator of
functional importance than correlation and thus yield substantially
higher LOD values for being affected by disease mutations. We
performed this analysis at different conservation cutoffs to get an
impression of the degree of conservation required to detect
functional importance.
As expected, we found well conserved positions to be clearly
enriched in disease mutations, and we observed a correlation
between the degree of conservation and the LOD score
(Figure 3C,D). Depending on the conservation measure and
cutoff, well conserved positions were &1:8{2:5 times as likely to
be affected by known disease mutations as random positions
(LOD&0:8{1:3). As expected, conservation clearly outperforms
correlation. Given the obvious link between conservation and
functional importance, the numbers for correlated positions are
surprisingly high. Furthermore, the LOD values for correlation
remain remarkably stable over a fairly wide range of conservation
thresholds indicating that the correlation signal is not merely an
artifact caused by relatively well conserved positions which happen
to also correlate. Taken together, these results suggest that
evolutionary conservation is a useful measure for the assessment
of disease-susceptibility and thus functional significance of amino
acid positions in a protein.
Non-contact correlations?
Other groups have previously demonstrated that correlated
positions without physical contact do occur in protein structures
[28,34] and, in a recent study, Noivirt-Brik et al. have
demonstrated the emergence of long-range interactions in lattice
models of proteins [35].
In the dataset analyzed in our own work, we found that only
2714 out of 16555 (16.4%) of correlated pairs had a distance of less
than 5.5A ˚ which would imply physical contact. If the distance
threshold is relaxed to a generous 8.0A ˚, still only 17.4% are in
proximity. Thus, even applying a very permissive threshold, the
majority of correlations is observed between residues which are not
in direct contact – an observation compatible with the hypothesis
of functional correlations.
Of course, many positions correlate with more than one other
residue and accordingly, some of these correlations coincide with
contacts while others do not. In our data, 29.6% of all correlated
positions had at least one contact correlation. For the positions
which were found to be both correlated and relevant for disease
31% had at least one contact ƒ5:5A ˚.
Figure 2. Disease mutations are overrepresented in correlated positions. Distribution of log odds (LOD) scores for individual proteins. All
proteins for which no score could be obtained were excluded. A: All proteins; B: proteins with §10 disease mutations. The bars at -Inf represent cases
where no position was both correlated and associated with disease, resulting in an LOD of {?, as discussed in the main text.
doi:10.1371/journal.pcbi.1000923.g002
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enriched in disease mutations. Out of 4960 correlated residues
without a single contact, 252 (5.0%) were also disease positions.
This corresponds to 1.3 fold increase over the expectation (LOD
= 0.39). Due to the small sample size the latter is not statistically
significant. Nevertheless, the trend is encouraging and points in
the direction of the hypothesis of functionally relevant non-contact
correlations. Table 2 summarizes the results for correlation,
conservation and residue contacts.
Comparison with active sites
The most plausible explanation for a connection between
correlated mutations and disease mutations is that correlated
mutations indicate functional relevance of the respective residues.
Figure 3. Interdependence between correlation and sequence conservation. LOD distribution for different conservation thresholds: (A, B)
LOD for correlated residues at different levels of conservation. (A) BLOSUM conservation score, (B) fractional identity. Each dot represents the LOD
score achieved using a specific conservation cutoff. A cutoff of 0.4 indicates that for the calculation of the global LOD score only the residues which
have a conservation score ƒ0:4 were taken into account. (C, D) LOD scores for sequence conservation irrespective of residue correlation. Here, a
cutoff of 0.4 indicates that the global LOD represents all positions with a conservation score §0:4. The LOD remains largely stable over wide ranges
of sequence conservation (A,B). Residue conservation yields LODs similar to correlation for intermediate levels of conservation and performs better
for very high conservation.
doi:10.1371/journal.pcbi.1000923.g003
Correlated Disease Mutations
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functionally active themselves or correlate with functionally
important positions in the protein. That would imply that we
should find significant enrichment of active sites in correlated
position, too.
We used the SwissProt feature annotation to test this hypothesis
and found that 3.7% of functional sites are annotated with at least
one disease associated point-mutation in HGMD. That means that
functional sites are roughly twice as likely to host disease mutations
than expected. We carried out an analysis of enrichment in
correlated positions with the functional site data and found it even
stronger than for the disease mutation data (LOD = 1.04,
pv2:2:10{16). When active sites and HGMD mutations are
combined into a single set the resulting enrichment lies between
the results for disease and functional sites (LOD = 0.88,
pv2:2:10{16). So both types of information show the same trend
to lie in correlated positions.
Next, we asked the question if a position would be more likely to
be involved in disease if it was correlated with another disease site
or a known functional residue. We found that residues which are
correlated with a disease position or a functional site are 5.2 and
2.9 times more likely to be disease positions themselves than
randomly chosen residues, respectively. These numbers indicate
that not only is correlated mutation itself an indicator of disease-
relevant sites but apparently functional/disease positions seem to
be preferentially correlated with each other. As for the disease
positions analyzed above, we found that only a modest fraction
(18%; 5.5 A ˚ threshold) of functional positions which show
significant correlation are involved in physical contact and thus
the majority are non-contact correlations.
Structural preferences
So far, correlation was the only variable taken into account in
our analysis, but other structural features may also contribute to
the potential of a correlated residue to be associated with disease.
In order to test if basic structural features of a position affect our
results, we investigated the accessibility of a residue in this context.
This analysis was carried out in the subset of proteins with known
structure which is much smaller than the full data set. The global
LOD for disease in correlated positions in this smaller subset is
0.39. Interestingly, correlated residues that were exposed showed
an LOD of 0.73 while partially and fully buried correlated residues
had LOD of only 0.42 and 0.1, respectively.
Another obvious structural condition is the local secondary
structure. Our analysis revealed that correlated positions are most
likely to be associated with disease when they are embedded in an
a-helix (LOD=0.47) followed by turns (LOD=0.37) and much
weaker in in b-sheets (LOD=0.09). This ranking is in part
connected to the different accessibility found in these secondary
structures: helices and turns are known to exhibit a much larger
fraction of exposed residues than beta sheets and our sample is in
accordance with this. Furthermore, in our data, the probability of
a position being associated with disease is significantly negatively
correlated with accessibility and the same is true for the probability
of showing co-evolution with another residue. In a logistic
regression model of the disease probability vs. accessibility and
secondary structure, the secondary structure just barely achieved
significance (p~0:0485) while accessibility was highly significant
(pv2:2:10{16). For the probability of a residue to co-evolve with
another one, secondary structure was not a significant predictor
(p~0:1446) while accessibility was highly significant again
(pv2:2:10{16).
As we have seen above, the enrichment of correlated disease
residues is more pronounced in exposed sites. This observation
appears plausible because much of the functional features of a
protein are located on its surface: regulatory modifications,
interactions with other proteins and binding sites for substrates
need to be accessible. As we also find co-evolving residues to favor
accessible locations, the above numbers come as no surprise.
Contributing to prediction
Phenotypic consequences of mutations are determined by many
different factors like functional role of the protein, specific amino
acids involved, structural properties etc. Accordingly, no single
feature can be expected to be a strong predictor on its own and
correlation is no exception. Tools like SIFT [36] or PolyPhen [12]
combine different signals into an integrated prediction of
phenotypic effects of mutations. Currently, correlated mutation
is not among the features analyzed by these programs. Based on
our results presented above, we would expect that adding the
correlation signal to these tools would further improve their
predictions. A full assessment of this expectation would require
access to the source code of these tools, which we did not have. On
the other hand, we can analyze the overlap between predictions by
integrated tools and the correlation data in order to estimate if the
correlation data is fully included in these predictions or not. We
Table 2. Summary of performance.
subset TD C D ^ C LOD p-value
Conservation (^ c cblosum§0:0) 741436 14211 459030 10273 0.22 v2:2:10{16
Conservation (^ c cblosum§0:5) 741436 14211 144591 4892 0.82 v2:2:10{16
Conservation (^ c cblosum§0:8) 741436 14211 53443 2402 1.23 v2:2:10{16
Contact 70589 2747 59079 2522 0.13 v2:2:10{16
Correlation 741436 14211 62365 1988 0.73 v2:2:10{16
Correlation (^ c cblosumƒ0:0) 287029 3961 16271 388 0.78 v2:2:10{16
Correlation (^ c cblosumƒ0:5) 599322 9328 49254 1463 0.93 v2:2:10{16
Correlation (^ c cblosumƒ0:8) 688790 11799 61802 1955 0.88 v2:2:10{16
Correlation, non-contact 70589 2747 4960 252 0.38 0:0018
P-values were computed using Fisher’s exact test. T: number of all residues; D: number of disease mutations; C: number of correlated positions; D ^ C: number of
correlated residues affected by disease-associated mutations.
doi:10.1371/journal.pcbi.1000923.t002
Correlated Disease Mutations
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signal in a set of 813 proteins featuring 8838 known disease
mutations and 5730 substitutions unlikely to cause disease (see
Materials and Methods). While the majority of the correlated
positions in the disease mutation set were predicted to be
damaging by either or both of the prediction programs, roughly
20% of the correlated positions were not. These numbers suggest
that the correlation data is at least partially complementary to the
results produced by both tools and thus has the potential to
improve predictions (Figure 4). Furthermore, we carried out a
multiple logistic regression, modeling the probability of disease
association by the predictions by SIFT, PolyPhen and correlation
and found all three terms to make highly significant contributions
to the model (pv10{16).
Case studies
In the previous sections we analyzed the dependence between co-
e v o l v i n gp o s i t i o n sa n dk n o w nd i s e a s em u t a t i o n s .W ew e r ea b l et o
demonstrate that correlated mutations are associated with disease
significantly more frequently than expected and found similar results
for sites known to be functionally active. In the following case studies
we present two examples of proteins with long-distance correlations
and discuss the functional aspects of the residues involved.
Proline dipeptidase
The human protein PEPD (UniProt: PEPD_HUMAN) is a proline
dipeptidase which plays an important role in the recycling of
proline during the final stages of degradation of collagen and
dietary proteins. The enzyme hydrolyzes dipeptides with a prolyl
or hydroxyprolyl residue in the C-terminal position. For catalytic
activity, binding of 2 manganese ions per subunit is required as a
co-factor [37,38]. Swissprot annotation marks residues D276,
D287, H370, E412 and E452 as responsible for manganese
binding [39,40].
Mutations of the PEPD protein have been identified as the
cause of autosomal recessive prolidase deficiency (PD). E.g.
Ledoux et al. have characterized several disease-causing point
mutations in the PEPD protein [41]. Their data show the different
extent of enzyme inhibition by these mutations. For instance, the
R184Q mutations resulted in a residual activity of 7.4% compared
to the wild type enzyme. The G278D and G448R mutations
caused complete abrogation of peptidase activity. Other sources
have found residues D276, S202 and E412 to cause the same
disorder when hit by point mutations [42–44].
The phenotypic consequences of mutations involving positions
276 and 412 are easily explained by the fact that these are directly
involved in metal binding. Positions 278 and 448 are in close
proximity to these functional sites so it does not come as a surprise
that they are critical.
R184 and S202 on the other hand, are situated far away
from the metal binding sites in the primary sequence. While
S202 gets close to the metal binding region in the three
dimensional structure, R184 is located quite distant from this
area. So why do point mutations at these sites cause disease? Of
course, one possibility is that the enzyme function is destroyed
by mechanisms totally unrelated to metal binding, but
constructing a link to the important functional sites is another.
We find that position 184 shows a strong co-evolution
connection to positions 453 and 277 which are both in direct
proximity of the metal binding residues (Figure 5a). Position
202 also shows a correlation with positions 277 and 184. We
thus suggest that both R184Q and mutations of S202 do in fact
inhibit manganese binding mediated by a non-contact interac-
tion between these residues.
In summary, all known PD causing point mutations are either in
close proximity to the critical residues or a correlated mutation
link to such residues can be found. Figure 5b shows the spacial
relations of the metal binding residues and some of the correlations
found in this region.
Upon close inspection of the co-evolution connections depicted
in Figure 5a, it is easy to see that the correlation links are not
distributed evenly across the protein. Some residues or regions are
connected to others by multiple arcs. Also, many positions are not
only connected to each other but also share common neighbors
hinting at a network of correlated positions. This observation
seems to hold for the entire group of metal binding sites and
disease positions discussed above: all of these positions seem to be
part of a small correlation network.
Figure 4. Venn diagrams of SIFT, PolyPhen and correlated mutations in (A) disease and (B) non-disease positions. For SIFT and
PolyPhen, maybe and possibly damaging were treated as non-damaging.
doi:10.1371/journal.pcbi.1000923.g004
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Our second example is AK1, the human adenylate kinase
isoenzyme 1. AK1 catalyzes the reversible transfer of the terminal
phosphate group between ATP and AMP that is essential for cell
maintenance and growth.
Point mutations of AK1 cause hemolytic anemia due to
adenylate kinase deficiency (OMIM: 612631). AK1 catalyzes the
reaction of ATP and AMP to two ADPs that is done by two
nucleotide bindings regions. According to SwissProt annotation,
the ATP binding site is located at residue 15–23 and the AMP
binding site comprises residues 39 and 94–101.
Several different positions of the protein have been found to result
in an altered phenotype upon mutation. Residue G40 is in direct
neighbors of the nucleotide binding T39 while Y164 is somewhat
further away. Some other positions (G64 and R128) are located inthe
neighborhood of these active sites in the 3D structure (Figure 6).
Figure 5. Correlation patterns in the human proline peptidase PEPD. (A) circular representation of linear protein sequence. Arcs indicate
residue correlations. (B) Structure view indicating selected correlations as dashed lines. Metal binding residues are shown with side chains (PDB:
2iw2). (A,B) Disease associated positions are marked red, functional sites in blue.
doi:10.1371/journal.pcbi.1000923.g005
Figure 6. Correlation patterns in the adenylate kinase isoenzyme 1. (A) circular representation of linear protein sequence. Arcs indicate
residue correlations. (B) Structure view indicating selected correlations as dashed lines (PDB: 2C95). (A,B) Disease associated positions are marked red,
functional sites in blue.
doi:10.1371/journal.pcbi.1000923.g006
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are located at or near correlated positions which link to or close to
the nucleotide bindings sites. As for the PEPD example, there
appears to be a network of correlated positions. Residue G64 is
directly linked to residue G40 that is a disease position itself and is
immediately adjacent to one of the binding site T39. In addition,
residue Y164 is directly linked to the disease residue G40. We
found correlated links between both nucleotide binding regions
and a direct link of G64 and G40 with residue G22 that is located
in the ATP binding site. Obviously, disease relevant mutations can
be ‘‘explained’’ by co-mutation links to binding sites or they are
not involved in correlations themselves but are located in their
close neighborhood (e.g. R128).
Both case studies illustrate that correlation networks may
connect residues located elsewhere on the protein structure to a
given disease associated mutation site. Disease affected positions
and their immediate neighborhood tend to be connected in the
network with other functionally important residues or regions
such as metal binding sites or binding sites. In some other cases,
disease-affected residues are located next to correlated residues
or in well-connected regions of the network. These linkages
could provide hints on the effects of disease-associated mutations
as the corresponding networks could be used to transport the
effects of point-mutations to functionally important regions.
Accordingly, correlation networks provide a novel basis for
selecting promising target residues for mutation studies or
estimating the potential effects of yet uncharacterized naturally
occurring mutations.
Multiple correlation
Above we mentioned small networks of correlated positions.
From a graph perspective, positions with a higher degree (number
of edges) should be more important than those with a low degree.
In order to test if this also applies to our correlation network with
respect to disease we analyzed the correlation graphs and found a
clear association between the degree of a position and its
probability to be associated with disease (Figure 7). Positions that
are correlated with increasing numbers of other positions are
increasingly more likely to be associated with disease (r~0:66,
p~7:05:10{6).
Discussion
In the past, analysis of residue co-evolution in proteins has been
applied to various problems mainly centered around the idea of
compensatory amino acid substitutions on protein contact
surfaces. Correlations not readily explained by contacts have been
discussed in the field and were simply labeled ‘‘noise’’ by many
groups [27,45,46]. New ideas in this field have been introduced by
many researchers and concepts such as a correlation backbone as an
element of protein structure or mapping functional sites to
correlation hotspots have been explored and illustrated by various
examples. First discussions of disease relevance have only recently
entered the literature and were restricted to selected proteins or
protein families [18,32]. To our knowledge, the data presented
above represents the first attempt at a comprehensive analysis of
evolutionary residue co-mutation in the light of disease associated
point mutations. Our data indicate that residues highly correlated
with others are indeed more likely to be associated with disease
than expected. Surprisingly, as little as 30 orthologous sequences
sufficed to detect a significant difference and considering only
orthologous groups with at least 125 proteins did not yield a
substantial difference.
Of course, a single parameter such as correlated evolution
cannot be expected to yield a high positive predictive value when
used in isolation but our findings clearly show that it is one
property to look for when judging the functional significance and/
or potential to cause a disease phenotype upon mutation. A fair
assessment of the value of such a measure is probably the direct
comparison to the most popular approach of using sequence
conservation as an indicator of functional importance. As our
Figure 7. Multiple correlations. (A) The degree (number of correlation partners) of a position in the correlation network is positively correlated
with the log odds of causing disease. As very large degrees are rare, substantial noise occurs at degrees above &20. For lower values the association
is clearly visible. Overall the association is substantial and significant (r~0:66, p~7:05:10{6). (B) Degree distribution of multiple correlations.
doi:10.1371/journal.pcbi.1000923.g007
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less than conservation but appears to be on the same order of
magnitude.
This has clear practical implications. Some diseases are caused
by large numbers of different point mutations in seemingly
random locations in the protein. Analysis of co-evolution could
serve as an interesting tool to explain some of these cases. Given
the rapidly decreasing cost of sequencing, the hunt for SNPs and
the trend towards personalized medicine, more and more data on
variations of unknown physiological consequences will be
gathered. Analysis of correlated mutations could prove to be a
useful complement to data on conservation, structure and other
protein features in the attempt to understand functional relevance
of mutations.
We found that the correlated mutation detection was largely
independent of conservation signal over a wide range and that the
majority of correlations did not coincide with contacts in the subset
of proteins for which protein structure data was available.
Accordingly, we believe that the data indicate a genuine signal
of co-evolution among functionally linked positions which are
vulnerable to mutations. These findings are in line with the work
on structural determination of protein domains based on the co-
mutation signal [28] and provide good evidence for the concept of
long-distance associations within proteins.
Another interesting observation which we have not yet analyzed
systematically, is the role of ‘‘near-miss correlations’’, i.e.
correlations between residues in the direct neighborhood of
functionally essential sites and/or known disease-associated
positions. This concept is similar to our observation that
sometimes point mutations causing disease are located next to
critical residues without actually destroying them. In some cases
one may argue that hitting the critical residue itself would be too
drastic a defect to be viable, in others a simple mechanistic point of
view arguing that local changes are likely to influence their direct
neighborhood may suffice as an explanation.
Many conceptually different algorithms have been developed to
detect residue co-mutation. Fodor et al. have shown that these
algorithms have a preferred level of conservation to extract
significantly correlated pairs [25]. In our work, we used the OMES
algorithm, as it was found to be among the best performers and
most robust methods for contact prediction. But that does not
necessarily imply that OMES is the single best choice for the
analysis of non-contact correlation or disease mutations under
each and every condition. We have preliminary data which shows
that other methods produce comparable LOD scores for the
global analysis, but differ in their performance depending on the
degree of conservation. In future work, we are planning to study
this in more detail and take advantage of differential preferences.
Correlated behavior of contact residues is a plausible and well
accepted concept but what mechanisms produce long-range
correlations? Lapedes et al. have suggested subsequent pairs of
contact residues which extend the co-variation along a chain of
contact-correlations [47]. This model is in good agreement with
the concept of networks of correlated positions like the ones seen in
our case studies and other preliminary data.
Another possible explanation for long-range correlations is the
impact on proteinfolds. It is conceivable that amino acidsubstitutions
may change the orientation of neighboring secondary structure
elements by a few degrees. Such a change could easily impair protein
function. It is not too difficult to imagine another change on the other
side of such our helix to compensate this structural change and thus
keep the rest of the fold largely unaffected.
Russ et al. introduced the concept of correlated sites as an
architectural backbone of protein domains [29]. Many of the
correlations used in their model related to positions which are
clearly not in contact with each other and thus forming a correlation
backbone. This work suggest that co-evolving residues within a
protein contain more information than the mere potential to be in
physical contact.
Methods like OMES that solely operate on multiple sequence
alignments in analyzing correlations have previously been
criticized for being ‘‘tree agnostic’’ – i.e. ignoring the underlying
phylogenetic tree in their assessment. Others have argued that no
substantial gain is achieved by tree-aware methods [48]. In order
to test if using the phylogenetic information substantially affects
our results, we repeated all major analyses with the algorithm of
Noivirt et al. [49]. Although this method yielded a slightly lower
LOD than OMES (0.63 vs. 0.73), all of our conclusions could be
confirmed in this re-analysis.
In summary, we believe that researchers should not only look at
conservation in their judgment of functional significance of residues
in the protein sequence. Correlation patterns between residues
clearly provide additional evidence which should not be ignored.
Materials and Methods
Mutation data
Disease mutation data was obtained from the HGMD database
[2], a comprehensive collection of mutations underlying human
inherited disease. Access to the full HGMD release 7.3 was licensed
from Biobase, Germany (http://www.biobase-international.com).
Out of a total of 73 411 mutation entries 41628 referred to
point mutations, while the rest represented other types of
mutation. From this initial set of 2253 human proteins, we
eliminated all entries describing mutations leading to stop codons
and thus truncation of the full length protein. The final data set
comprised 32 923 disease-related amino acid substitutions affect-
ing 27 522 unique positions in 2067 different proteins.
Orthologous protein sets
Groups of orthologous proteins were downloaded from the
STRING database (release 7.0) [50] where these were generated
for their COG-interaction mode. Because some of these
computationally derived orthologous groups contain a very broad
range of sequence homology which in some cases may go beyond
orthologs, we removed all sequences which failed to cover at least
80% of the human reference sequence in the multiple alignments
according to STRING.
Often, such ortholog sets contain many sequences from very
closely related species resulting in an excessive apparent sequence
conservation and thus undue weight of almost identical sequences
which does not reflect the evolutionary situation but the bias in
protein selection. To overcome this bias, we iteratively removed
near-identical sequences from the ortholog sets. We calculated the
sequence identity of all pairs in global alignments. If two sequences
were over 90% identical, one of them was picked at random.
Very small ortholog sets cannot reasonably be expected to allow
valid conclusions about evolutionary correlation, because the
resulting multiple alignments simply do not contain enough
sequences. In the literature, a wide range of minimum ortholog
clusters sizes have been applied. While some used as little as 15
proteins [21,51,52], other required more than 125 different
orthologs [18,53,54]. In our study, we initially used all clusters
with at least 30 orthologous proteins, which is a very common
cutoff [53,55]. In addition, we also performed our analysis on a
more stringent data set by using a threshold of §125. The former
threshold yields 1153 human proteins with their orthologs, while
the more strict cutoff still leaves us with 855 such clusters.
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We used the feature annotation from SWISSPROT [39,40] to
identify functionally relevant positions in each of the disease
associated proteins with a sufficient number of orthologs. We
included the following feature tags in our analysis: CA_BIND
(calcium-binding), DNA_BIND (DNA binding), NP_BIND (nucleo-
tide phosphate-binding), ACT_SITE (involved in enzyme activity),
METAL (metal binding), BINDING (binding of unspecified chemical
group),MOD_RES(posttranslational modification)andLIPID (lipid
binding). In total, we obtained 12021 functional residues in 745
proteins.
Multiple sequence alignments (MSA)
Alignments of orthologous proteins were carried out using
MUSCLE 3.6 [56] with default parameters. To reduce compu-
tational requirements we limited each ortholog set to a maximum
of 300 sequences, after filtering, by selecting a random sample of
299 sequences plus the human reference sequence, which always
needs to be present for analysis.
Correlated mutation analysis
Correlated mutations were analyzed using the OMES (Ob-
served Minus Expected Squared) algorithm. The OMES method
is based on the x2 goodness-of-fit test and compares the observed
co-occurrence of amino acid x at position i and amino acid y at
position j to the expected co-occurrence at positions i and j
[20,25,57]. In this work we use the OMES variant defined by
Fodor et al. [25]. We computed OMES correlation scores for all
combinations of positions in each protein based on the multiple
sequence alignments described above. Following the previously
described approach we selected the top L=k co-evolving residue
pairs where L is the length of the respective protein and k is a
constant which is often set to 5 [55,58]. To assess the influence
of the constant k we evaluated our findings over a range of
k[½0:01,50 . Based on this analysis, the commonly used value of
k~5 appears to be a good choice for our application: For values
of k from 0 to 5 the observed LOD shows a steep increase.
Somewhere around k~5 or 10 the curve adopts a much more
moderate slope (Figure 8). A choice of k~5 takes advantage of the
initial LOD improvement without including excessive numbers of
positions in each protein.
For further analysis, a sequence position was called correlated if it
had at least one significant correlation with another position
according to the above criteria.
Sequence conservation
Two different measures of sequence conservation were
computed for each position of a human protein. The BLOSUM
conservation-score cblosum for each human residue was calculated
by summing over the BLOSUM-scores for each residue pair
between the human amino acid and all ortholog residues in the
column of the MSA and normalizing to the maximum score for
the given residue:
cblosum~
Pn
i~1 s(X0,j, Xi,j)
s(X0,j, X0,j):(n{g)
where Xi,j is the jth residue of sequence i in the MSA; n is the total
number of sequences; g is the number of gaps in column j; X0
refers to the human reference sequence and s(x,y) is the score for
amino acids x and y according to the BLOSUM62 scoring matrix
[33]. As BLOSUM scores can be negative, cblosum[½{1; 1 
The second approach simply computes the fraction of residues
identical to the reference sequence X0 for column j of the MSA:
cident~
Pn
i~1 (X0,j:Xi,j)
n{g
Structural contacts
Protein structure analysis was performed for all proteins of the
filtered set for which at least a partial crystal structure was
available from the PDB database [59]. 238 proteins fulfilled this
criterion. The spatial distance between correlated residue pairs
was calculated taking into account all non-hydrogen side chain
atoms of both amino acids. Two residues were considered to be in
contact with each other, if the smallest distance between any pair
of their non-hydrogen atoms was ƒ5:5 A ˚. This represents a
commonly applied threshold – other groups have used distance
cutoff in the range 5.0A ˚–8.0A ˚ using the closest non-hydrogen or
Cb atoms, respectively [20,53,55]. In order to exclude local
contacts in secondary structure elements, such as in a-helices, we
only considered residue pairs outside a window of 10 positions up-
and downstream of a given position.
Some studies on correlated mutations have computed distances
solely based on Cb atoms (Glycine: Ca) and a 8.0A ˚ cutoff [25]. We
provide additional data using this definition in the Text S1.
Residue accessibility
The accessible surface area (ASA) was computed with DSSP
[60] and converted to a relative solvent accessibility (RAS) by
dividing by the maximum possible ASA of the respective amino
acid. The data was discretized into three accessibility states: buried
(RSAƒ7%); intermediate (RSAƒ37%) and exposed (RSAw37%).
Identification of non-disease mutations
Amino acid substitutions with a low chance of causing harm
were identified with a strategy used by [61]. The rationale of this
Figure 8. Influence of correlation cutoff L=k. Commonly, L=5 (i.e.
k~5) is used. At first a substantial increase of LOD can be observed
with increasing values of k. Once k reaches values of &5{10 the steep
increase is replaced by a quite moderate slope.
doi:10.1371/journal.pcbi.1000923.g008
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evolution are very unlikely to cause disease when observed in
humans, at least for closely related species. We selected all human
proteins from our set for which we were able to identify
mammalian orthologs (from the ortholog clusters provided by
the STRING database [50]) with at least 95% identity to the
human sequence. Orthologs were only considered if they covered
at least 80% of the human sequence in a pairwise alignment. 813
proteins satisfied both criteria. Amino acid substitutions found in
the orthologs were considered non-damaging.
Significance testing and bootstrapping
Statistical significance of enrichment of disease mutations in
correlated positions was assessed by two different means. First we
used Fisher’s exact test for count data comparing the proportions
of disease-annotated residues in correlated vs. non-correlated
positions. In addition, we performed a 1000-fold permutation test
in which we shuffled the disease/non-disease tags of the entire data
set in order to obtain the empirical density function of the log odds
(Figure 1). In order to assess the robustness of the observed LOD
value we performed a 1000-fold bootstrapping of columns of the
multiple sequence alignments. I.e. in each bootstrap we sampled,
with replacement, from the columns of each of the multiple
sequence alignments in the data set and then re-computed the
LOD value for the entire re-sampled data set.
Computation and visualization
All analysis programs for this work were written in Python,
except for the program for correlated mutation analysis which was
implemented in Java. Final data analysis and statistics was
performed with the R statistical language [62]. Visualizations of
correlations in the linear sequence were created with Circos [63].
Protein structure images were made with PyMOL (http://pymol.
sourceforge.net/).
Supporting Information
Text S1 Supplementary analysis.
Found at: doi:10.1371/journal.pcbi.1000923.s001 (0.27 MB PDF)
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